Latest Notifications: New Drugs and Clinical Trials

Last Updated on June 25, 2023 by The Health Master

Download Latest Notifications: New Drugs and Clinical Trials

The Government of India issues notifications from time to time, which are published by the Department of Publication and printed regularly by the Government of India Printing Presses.

We have provided some of the notifications relevant to the above-said topic, Click on the below links for more information:

2023

GSR No. 364(E) dt 11-05-2023 Draft New Drugs and Clinical Trials (Amendment) Rules, 2022

GSR-175E-dt-09-03-2023-New-Drug-and-Clinical-Trial-Amendment-Rules-2023-additional-testing-methods-to-assess-safety-efficacy-of-iPSC-included

2022

GSR-No.-835E-dt-22-11-2022-Draft-notification-Specific-requirements-on-non-clinical-studies-New-Drugs-and-Clinical-Trials-Rules-2022

GSR-778E-dt-14-10-2022-New-Drugs-and-Clinical-Trials-Third-Amendment-Rules-2022

S.O.-553E-dt-09-02-2022-Stockpiling-of-new-drug-under-phase-3-of-clinical-trial-New-Drugs-and-Clinical-Trials-Rules-2019

GSR-No.-32E-dt-21-01-2022-Draft-notification-Insertion-of-Proviso-for-deemed-approvals-in-Rule-8-under-New-Drugs-and-Clinical-Trials-Rules-2019

GSR-No.-21E-dt-18-01-2022-Designated-Registration-Authority-in-Form-CT-3-New-Drugs-and-Clinical-Trials-2nd-Amendment-Rules-2022

GSR-No.-14E-dt-13-01-2022-Final-notification-Rule-2-New-Drugs-and-Clinical-Trials-Amendments-Rules-2022

2021

GSR-767E-dt-27-10-2021-Draft-to-amend-rule-2-to-substitute-cell-or-stem-cell-derived-product-under-NDCTR-2019

GSR-605E-dt-31-08-2021-Standalone-Bioanalytica-New-Drugs-and-Clinical-Trials-Amendment-Rules-2021

GSR-No.-524-dt-02-08-2021-DRaft-New-Drugs-and-Clinical-TrialAmendment-Rules-2021

GSR-99E-dt-05-02-2021-Draft-notification-For-inclusion-of-provisions-related-to-the-registration-of-stand-alone-bio-analytical-laboratories-in-the-NDCT-Rules-2019

2020

GSR-No.-354E-05-06-2020-New-Drugs-and-trial-(amendment)-Rules-2020-draft

2019

GSR-227-E-dt-19-03-2019-New-Drugs-and-Clinical-Trials-Rules-2019

2018

G.S.R-360-E-dt.-10-04-2018-New-Drug-word-Patent-and-proprietary-substituted-as-word-Drug

2011

GSR-45E-dt-24-01-2011-Vaccines-and-Recombinant-are-new-drugs-Drugs-and-Cosmetics-1st-Amendment-Rules-2011

2009

GSR-738E-dt-09-10-2009-Amendment-in-the-notification-number-G.S.R.-578E-23rd-July-1983-Substitutes-FDC-of-Corticosteroid-with-any-other-drug-for-internal-use

---

Compiled by:
Rakesh Dahiya, SDCO cum Licensing Authority, FDA Haryana

---

Banned Drugs

Blood Bank / Centre

Cosmetics

COTPA

DPCO / NPPA

Drugs Act

DMROA

EC Act

General

Homoeopathic

Hospital – RMI

Medical Devices

NDPS Act

Testing Laboratories

---

For informative videos by The Health Master, click on the below YouTube icon:

• Govt Job: For Pharmacovigilance Associate at IPC
  December 2, 2023
• USFDA Approval granted for Ivabradine Tablets
  December 2, 2023
• Clinical Trials halted for the drug Lokelma
  December 2, 2023
• Battle Against Industrial Grade Excipients in Pharma Industry
  December 2, 2023
• Investigation into Tapentadol and Pregabalin: DCC recommendation
  December 2, 2023
• Govt Job: For Pharmacists at ECHS
  December 1, 2023

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: